DPYSL5 and lung carcinoma: The neurological diagnosis of the remaining four patients, two had myasthenia, thymoma, and CV2 (CRMP5) antibodies, and two had brain metastasis in the setting of lung cancer and SOX1 and Ma2 antibodies (Table 1).